Doctor Lon (BLCO.US) has successfully launched the advanced enVista Aspire artificial lens in the European Union.
Bausch + Lomb (BLCO.US) announced on Monday that the enVista Aspire monofocal and multifocal intraocular lenses (IOLs) have been approved for marketing in the European Union after receiving CE certification at the end of last year.
Bausch + Lomb (BLCO.US) announced on Monday that after obtaining CE certification at the end of last year, the enVista Aspire monofocal and toric intraocular lenses (IOLs) are now available on the market in the European Union.
The enVista Aspire combines new intermediate optimizing optical elements with the mature advantages of the enVista platform to meet the visual needs of the modern digital world.
Luc Bonnefoy, President of Bausch + Lomb Surgical, stated, "Surgeons around the world have long been aware of the advantages of the enVista platform."
As of the time of publication, Bausch + Lomb was up 2.42% in pre-market trading, at $18.19.
Related Articles
ZHAOJIN MINING (01818): The first phase of the 2024 Mid-Term Note (Innovation Note) will pay interest on May 16th.
Jinjian Cereals Industry (600127.SH) plans to increase the capital of its wholly-owned subsidiary by 29 million yuan.
On May 9, FIRST PACIFIC (00142) issued 10,000 shares under the Caina Technology stock option plan.
ZHAOJIN MINING (01818): The first phase of the 2024 Mid-Term Note (Innovation Note) will pay interest on May 16th.
Jinjian Cereals Industry (600127.SH) plans to increase the capital of its wholly-owned subsidiary by 29 million yuan.
On May 9, FIRST PACIFIC (00142) issued 10,000 shares under the Caina Technology stock option plan.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
